BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, February 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 20, 2019
View Archived Issues
New chemogenetics system could find clinical use
Read More
Kinase target as stroke target
Read More
Precision Biosciences initiates phase I/IIa study of PBCAR-0191 in relapsed/refractory B-ALL and NHL
Read More
CQDM awards grant to IMV and its collaborators to develop DPX-SurMAGE
Read More
Arch Biopartners receives approval for phase I study of Metablok in Australia
Read More
Transcription factor may be colitis immunotherapy target
Read More
Millendo Therapeutics initiates pivotal phase IIb/III ZEPHYR study of livoletide
Read More
Phase II data presented for MS-1819-SD recombinant lipase
Read More
IMP-761 inhibits antigen-specific T-cell-mediated immune responses in vitro and in vivo
Read More
Positive topline results presented from pivotal phase III EMPOWUR study of vibegron
Read More
OBE-022 demonstrates promising safety and PK in the first part of the PROLONG study
Read More
Trial supports uninterrupted edoxaban for atrial fibrillation undergoing catheter ablation
Read More
FDA places partial clinical hold on venetoclax trials in multiple myeloma
Read More
ICT completes pre-IND meeting with FDA for CAR-T candidate ICTCAR-014
Read More
Newave Pharmaceutical discloses new Bcl-2 inhibitors
Read More
Phase II trial begins in Taiwan with TJ-202 for relapsed or refractory multiple myeloma
Read More
Plex Pharmaceuticals presents dual FKBP12/FKBP52 inhibitors
Read More
New Tec family kinase inhibitors synthesized at GB005
Read More
FDA approves Zulresso for postpartum depression
Read More
BioTheryX patents IL-1beta, IL-6, IL-2 and TNF-alpha production inhibitors
Read More
The University of Kansas identifies new endoplasmin inhibitors
Read More
Merck KGaA and Pfizer discontinue JAVELIN Ovarian PARP 100 study of avelumab
Read More
Altimmune reports phase II extension study findings for NasoVAX intranasal influenza vaccine
Read More
Tesaro announces data from GARNET study of dostarlimab in endometrial cancer
Read More
Studies with cordycepin point to polyadenylation as a target for treating osteoarthritis
Read More
